Entrepreneurship and innovation enable Weill Cornell Medicine to bring discoveries to patients faster.

Weill Cornell Medicine investigators enjoy robust programs dedicated to nurturing, protecting and commercializing their discoveries. By translating groundbreaking research into revolutionary care through commercial partnerships, lifechanging diagnostics, treatments and healthcare solutions can reach patients faster than ever before. Weill Cornell Medicine Enterprise Innovation fosters a culture of innovation and entrepreneurship to build the next generation of leaders in life sciences industries and new ventures.

Enterprise Innovation

Weill Cornell Medicine Enterprise Innovation engages and collaborates with Weill Cornell Medicine faculty and trainees while fostering alliances with leaders in the biomedical industry and business and investment community.

Scientists Pitch Medical Innovations at 2023 Biomedical Business Plan Challenge

Six teams pitched their innovations at the 2023 Biomedical Business Plan Challenge Final Pitch Day competition for $100,000 in prize money.

On-Demand Male Contraceptive Shows Promise in Preclinical Study

An experimental contraceptive drug candidate temporarily stops sperm in their tracks and prevents pregnancies in preclinical models, demonstrating that an on-demand male contraceptive is possible.

Engineering, Weill Cornell Medicine Pilot M.D.-M.Eng. Degree

The program, part of a cross-college initiative to accelerate engineering innovations in medicine, allows Weill Cornell Medicine medical students to earn a one-year Master of Engineering degree.

Sixth Annual Symposium on Entrepreneurship and Academic Drug Development Highlights Expanding Entrepreneurial Ecosystem

The sixth annual Symposium on Entrepreneurship and Academic Drug Development showcased Weill Cornell’s rich array of programs for supporting faculty.
Views on Innovation
Dr. McGinty
Dr. Barbara Hempstead, Dean, Weill Cornell Graduate School of Medical Sciences
Our accomplished physicians and scientists have a legacy of catalyzing research discoveries into new modalities and therapies that help transform human health.
Dr. John P. Leonard, Senior Associate Dean of Innovation and Initiatives
Getting new innovations across the finish line requires collaboration, often with industry partners, to scale up findings for application in healthcare.
Dr. William Polvino, CEO of Bridge Medicines
Tri-Institutional Therapeutics Discovery Institute and Bridge Medicines put the skill of a pharmaceutical company on the campuses of three great institutions.
Dr. Francis Barany
Dr. Francis Barany, Professor of Microbiology and Immunology
The professionals at Enterprise Innovation possess strong first-hand knowledge of what it takes to start a company.